Stryker received a higher than expected number of femoral head/hip stem dissociation complaints for certain sizes of the LFIT V40 Femoral Heads.
Hospitals and surgeons are required to inform product users of the notification and forward the notice to everyone who needs to be aware in their organization. Providers and Stryker branches are not required to return the product as part of the notification.
More articles on devices and implants:
Safe Orthopaedics acquires Qspine’s sales force: 5 insights
Medicrea earns world’s 1st FDA approval for patient-specific cages: 5 things to know
Looking to enter the spine market? See the Xoran, Fiagon partnership
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
